Thermo Fisher launches Big Foot cell sorter in

vice performance.

About Rubicon Research’s capabilities

We have a 15,000 square feet development and testing facility specializing in pulmonary and nasal drug delivery systems in Concord, Canada. It is a US FDA inspected and Health Canada approved laboratory and facility. Our manufacturing facility includes fully automated filling lines for unit dose and multidose nasal sprays.

From development to commercial

Our capabilities cover both development and commercial scale manufacture of unit dose, bidose, and multi-dose nasal sprays in environmentally controlled production facilities. With an excellent history of regulatory approvals, we can onboard projects at any stage of their lifecycle—from initial concept, through formulation and analytical method development/ optimization, clinical manufacturing, and commercial manufacturing.

To know more visit www.rubicon.co.in or contact bd@rubicon.co.in

India

First-of-its-kind cell-sorting technology supports researchers advancing new therapies

Thermo Fisher Scientific, the world leader in serving science, recently announced the launch of the Bigfoot Spectral Cell Sorter in India. The first-of-its-kind cell-sorting technology provides easy-to-use, high-speed cell sorting by complimenting conventional with spectral sorting and analysis.

Cell sorting enables scientists to isolate live, homogenous cell populations to answer critical questions regarding cellular changes that take place under certain conditions, stem cell differentiation and cellular response to drugs. These insights are useful in genome editing, vaccine studies, drug and toxicity screening, and cell and gene therapy development, among other applications.

The Bigfoot Spectral Cell Sorter was designed to address challenges faced by researchers, offering unique benefits including:

◆ Speed at scale: The instrument accelerates sorting up to

10 times faster than competitors.

◆ Versatility of detection: Bigfoot Spectral Cell Sorter can be configured with up to nine lasers and 60 detectors, providing adaptability for both standard fluorescence detection and spectral unmixing.

◆ Personnel and product protection: A custom-designed, built-in safety enclosure and an Aerosol Management System (AMS) provide safety and protection in a compact footprint.

“Growing interest in areas of immuno-oncology, purification of engineered microbes and vaccine development has increased demand for cytometry analysis and sorting techniques with greater multiplexing capabilities. The Bigfoot Spectral Cell Sorter addresses researchers’ need to gain deeper biological insights and advance their work in the development of new therapies,” said Amit Chopra, Managing Director, India and South Asia, Thermo Fisher Scientific.

Thermo Fisher acquired cellsorting technology assets from Propel Labs, a wholly-owned subsidiary of SIDIS Corp, in 2021.